ESSA Pharma第二季度每股收益$（0.14）击败$（0.19）估计

ESSA Pharma (NASDAQ: EPIX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 26.32 percent. This is a 30 percent increase over losses of $(0.20) per share from the same period last year.